TRAW: Traws Pharma, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 9.89
Enterprise Value ($M) 4.48
Book Value ($M) -2.03
Book Value / Share -0.56
Price / Book -4.87
NCAV ($M) -2.05
NCAV / Share -0.56
Price / NCAV -4.84

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) -6.21
Return on Equity (ROE) -13.19

Liquidity (mrq)
Quick Ratio 1.07
Current Ratio 1.07

Balance Sheet (mrq) ($M)
Current Assets 8.92
Assets 8.94
Liabilities 10.97
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-14 13G Ikarian Capital, LLC 9.99
02-14 13G Alyeska Investment Group, L.P. 9.90
02-13 13G Ayrton Capital LLC 9.90
01-29 13D/A Orbimed Advisors Llc 19.90 25.65
01-08 13G Perceptive Advisors Llc 9.90
04-08 13D Viriom, Inc. 11.60

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q
2024-08-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-04-29 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K/A (Amendment No. 1)

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-03-14 2,729 14,930 18.28
2025-03-13 1,606 8,009 20.05
2025-03-12 5,918 30,470 19.42
2025-03-11 3,774 15,691 24.05
2025-03-10 5,667 43,372 13.07

(click for more detail)

Similar Companies
TNFA – TNF Pharmaceuticals, Inc. TNXP – Tonix Pharmaceuticals Holding Corp.
TPST – Tempest Therapeutics, Inc. TTNP – Titan Pharmaceuticals, Inc.
UNCY – Unicycive Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io